GGrantIndex
Sort

8,912 grants matching sars cov 2

Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury

$533,933
Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2020 · AI

Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury

$533,933
Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2019 · AI

Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury

$533,933
Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2018 · AI

Pitt-Ohio State Clinical Trials Unit Administrative Supplement

$533,144
John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2020 · AI

Core B - Clinical Core

$533,133
Rachel Margaret Presti · Washington University · U19 · FY2025 · AI

Infection and Rapid Transmission of SARS-C0V-2 in Ferrets

$532,961
Jae U Jung · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · AI

Structural and functional analysis of the coronavirus spike protein fusion peptide

$532,013
Gary R Whittaker · Cornell University · R01 · FY2020 · AI

MEDSCAN: Mobile Enabled Diagnostics for Schistosomiasis Control Analytics

$531,973
Thomas F Scherr · Vanderbilt University · R01 · FY2021 · AI

CoVPN 3002 A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults to Determine the Safety, Efficacy, and Immunogenicity of AZD1222 for the Prevention of COVID-19 LC2

$531,957
Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI

Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19

$531,940
Matthew J. Flick · Univ Of North Carolina Chapel Hill · R01 · FY2024 · HL

Human Herpesvirus 6B in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome pathogenesis: temporal analysis of viral reactivation and immunity to elucidate cause vs effect

$531,652
Eliana Lacerda · London Sch/Hygiene & Tropical Medicine · R01 · FY2022 · AI

Role of RNA modifications in coronaviruses replication

$531,257
Marcos Morgan · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES

Immunologic and Predictive Features of MIS-C

$531,183
Dusan Bogunovic · Columbia University Health Sciences · R01 · FY2024 · HD

COVIDgene: Host genetics of SARS_CoV_2 infections

$531,120
David L Thomas · Johns Hopkins University · R01 · FY2020 · AI

Structure of the full-length spike protein of SARS-CoV-2 in the context of membrane

$531,000
Bing Chen · Boston Children'S Hospital · R01 · FY2020 · AI

An Engineered Robotic Plasma Array for Large Area Surface Decontamination

$530,650
Jim Browning · Boise State University · R21 · FY2021 · EB

Global Research Endeavors to Advance Treatment of Neurological Disorders in Africa (GREAT Neurology)

$530,560
Gretchen Lano Birbeck · University Of Rochester · R35 · FY2024 · NS

Core B: Organoid Core

$530,054
Calvin J Kuo · Stanford University · U19 · FY2023 · AI

Automating Viral Genome Annotation and Quality Control for Viruses of Public Health Importance

$529,500
Alexander L Greninger · University Of Washington · R03 · FY2025 · LM

Human Herpesvirus 6B in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome pathogenesis: temporal analysis of viral reactivation and immunity to elucidate cause vs effect

$529,473
Jackie Cliff · London Sch/Hygiene & Tropical Medicine · R01 · FY2025 · AI

Core B: Organoid Core

$529,054
Calvin J Kuo · Stanford University · U19 · FY2022 · AI

Core B: Shared Resource Core For Characterizing Antibody Responses To SARS-CoV-2 And Other Pathogenic Human Coronaviruses

$528,796
Aravinda M De Silva · Univ Of North Carolina Chapel Hill · U54 · FY2020 · CA

Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis

$528,500
Matthew Bryan Frieman · University Of Maryland Baltimore · R01 · FY2014 · AI

REACH-OUT (Research, Engagement and Action on COVID-19 Health Outcomes via Testing)

$528,295
Matthew Wayne Decamp · University Of Colorado Denver · U01 · FY2023 · MD

BIOINFORMATICS RESOURCE CENTERS FOR INFECTIOUS DISEASES: SARS-CoV-2 ACTIVITIES

$528,019
Rick Stevens · University Of Chicago · N01 · FY2022 · AI